Accredited Investors Inc. Amgen Inc Transaction History

Accredited Investors Inc.

$1.55 Billion
Q2 2024

A detailed history of Accredited Investors Inc. transactions in Amgen Inc stock. As of the latest transaction made, Accredited Investors Inc. holds 2,120 shares of AMGN stock, worth $678,739. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,120

Previous 2,116 0.19%

Holding current value

$678,739

Previous $601,000 10.15%

% of portfolio

0.04%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $1,051 - $1,277	4 Added 0.19%	2,120 $662,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $182,293 - $220,051	678 Added 47.15%	2,116 $601,000
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $8,438 - $9,519	-33 Reduced 2.24%	1,438 $414,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $437 - $542	2 Added 0.14%	1,471 $395,000
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $15,855 - $18,749	-74 Reduced 4.8%	1,469 $326,000
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $451 - $550	2 Added 0.13%	1,543 $373,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $8,245 - $10,476	36 Added 2.39%	1,541 $404,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $63,522 - $71,641	-283 Reduced 15.83%	1,505 $339,000
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $113,740 - $126,572	493 Added 38.07%	1,788 $435,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $2,192 - $2,425	-10 Reduced 0.77%	1,295 $313,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $2,585 - $2,958	13 Added 1.01%	1,305 $293,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $12,311 - $14,424	-58 Reduced 4.3%	1,292 $275,000
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $48,584 - $53,901	208 Added 18.21%	1,350 $329,000
Q1 2021 Apr 16, 2021	SELL	$221.91 - $258.6 $36,837 - $42,927	-166 Reduced 12.69%	1,142 $284,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $53,878 - $64,159	249 Added 23.51%	1,308 $301,000
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $21,587 - $24,007	92 Added 9.51%	1,059 $269,000
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $144,796 - $177,685	-732 Reduced 43.08%	967 $228,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $364 - $483	-2 Reduced 0.12%	1,699 $344,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $23,853 - $28,580	-137 Reduced 7.45%	1,701 $329,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $4,834 - $5,666	-29 Reduced 1.55%	1,838 $0
Q1 2019 Apr 17, 2019	BUY	$180.87 - $203.88 $56,250 - $63,406	311 Added 19.99%	1,867 $355,000
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $13,896 - $15,666	-75 Reduced 4.6%	1,556 $323,000
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $6,309 - $7,087	-38 Reduced 2.28%	1,631 $301,000
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $17,620 - $20,592	104 Added 6.65%	1,669 $285,000
Q4 2017 Jan 17, 2018	BUY	$168.79 - $188.59 $1,519 - $1,697	9 Added 0.58%	1,565 $272,000
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $260,303 - $297,196	1,556	1,556 $290,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.

Account

Accredited Investors Inc. Amgen Inc Transaction History